Ovarian Cancer Update: Lessons from Morphology, Molecules, and Mice
Explore this paper's citation graph
- Type
- review
- Published
- 2009-11-01
- Cited by
- 69
- References
- 32
- Access
- Open access
- OpenAlex
- https://openalex.org/W1853532732
- Semantic Scholar
- https://api.semanticscholar.org/CorpusID:38580402
Keywords
Serous fluid, Ovarian cancer, Serous carcinoma, Ovarian carcinoma, Clear cell
References
- K-ras activation occurs frequently in mucinous adenocarcinomas and rarely in other common epithelial tumors of the human ovary.
- Signal transduction by the Wnt family of ligands.
- Gene expression in ovarian cancer reflects both morphology and biological behavior, distinguishing clear cell from other poor-prognosis ovarian carcinomas.
- Ovarian tumorigenesis: a proposed model based on morphological and molecular genetic analysis.
- Perturbations of the AKT signaling pathway in human cancer
- Noninvasive and Invasive Micropapillary (Low-Grade) Serous Carcinoma of the Ovary: A Clinicopathologic Analysis of 135 Cases
- Patterns of p53 Mutations Separate Ovarian Serous Borderline Tumors and Low- and High-grade Carcinomas and Provide Support for a New Model of Ovarian Carcinogenesis: A Mutational Analysis With Immunohistochemical Correlation
- β‐Catenin mutation and expression analysis in ovarian cancer: Exon 3 mutations and nuclear translocation in 16% of endometrioid tumours
- Molecular genetics for the clinician
- Role of KRAS and BRAF gene mutations in mucinous ovarian carcinoma.
- TP53 mutations in human cancers: functional selection and impact on cancer prognosis and outcomes
- Origins and molecular pathology of ovarian cancer
- Frequent activating mutations of PIK3CA in ovarian clear cell carcinoma.
- Assessment of TP53 mutation using purified tissue samples of ovarian serous carcinomas reveals a higher mutation rate than previously reported and does not correlate with drug resistance
- The distal fallopian tube: a new model for pelvic serous carcinogenesis
- Grading Ovarian Serous Carcinoma Using a Two-Tier System
- Intraepithelial Carcinoma of the Fimbria and Pelvic Serous Carcinoma: Evidence for a Causal Relationship
- PTEN mutation, expression and LOH at its locus in ovarian carcinomas. Relation to TP53, K-RAS and BRCA1 mutations.
- Mouse model of human ovarian endometrioid adenocarcinoma based on somatic defects in the Wnt/beta-catenin and PI3K/Pten signaling pathways.
- Testing of two binary grading systems for FIGO stage III serous carcinoma of the ovary and peritoneum.
Cited by
- Vorläuferläsionen der Ovarialkarzinome
- Evidence for the antagonistic form of CXC‐motif chemokine CXCL10 in serous epithelial ovarian tumours
- Neutrophil Granulocytes in Ovarian Cancer - Induction of Epithelial-To-Mesenchymal-Transition and Tumor Cell Migration
- Investigation of TRAIL resistance in ovarian cancer cell lines and translational application in primary ovarian cancer cells
- Engineered microenvironments provide new insights into ovarian and prostate cancer progression and drug responses.
- The roles of parafibromin expression in ovarian epithelial carcinomas: a marker for differentiation and prognosis and a target for gene therapy
- EVALUATION OF P53, PTEN AND β-CATENIN IMMUNOEXPRESSIONS IN PRIMARY OVARIAN EPITHELIAL TUMORS
- CHARACTERIZATION OF TWENTY-FIVE OVARIAN TUMOR CELL LINES THAT PHENOCOPY PRIMARY TUMORS
- Clinicopathologic and Immunohistochemical Features of Ovarian Clear Cell Carcinomas in Comparison With Type I and Type II Tumors
- Targeting of follicle stimulating hormone peptide-conjugated dendrimers to ovarian cancer cells.
- Murine Model for Non-invasive Imaging to Detect and Monitor Ovarian Cancer Recurrence
- Androgens stimulate telomerase expression, activity and phosphorylation in ovarian adenocarcinoma cells.
- Revisiting ovarian cancer preclinical models: implications for a better management of the disease.
- MALDI Imaging Mass Spectrometry (MALDI-IMS)—Application of Spatial Proteomics for Ovarian Cancer Classification and Diagnosis
- The emerging role of CXC chemokines in epithelial ovarian cancer.
- Molecular and Functional Characteristics of Ovarian Surface Epithelial Cells Transformed by KrasG12D and loss of Pten in a Mouse Model in vivo
- Pathogenesis of the Endometriosis-Related Ovarian Neoplasms
- Current challenges and future directions in the management of ovarian cancer: Proceedings of the first global workshop on ovarian cancer
- Defect of tropomyosin-related kinase B isotype expression in ovarian clear cell adenocarcinoma.
- Targeting Signaling Pathways in Epithelial Ovarian Cancer
Related papers
- Clear cell adenocarcinoma of the ovary: a clinical analysis and comparison with serous carcinoma.
- Mixed Clear Cell/Endometrioid and Clear Cell/Serous Carcinoma of the Uterus are Clinicopathologically Similar to Pure Clear Cell Carcinoma: An NRG Oncology/Gynecologic Oncology Group (GOG-210) Study of 311 Women
- A comparison of clinico-pathologic characteristics of patients with serous and clear cell carcinoma of the uterus
- Morphologic changes in ovarian carcinoma after neoadjuvant chemotherapy: report of a case showing extensive clear cell changes mimicking clear cell carcinoma.
- Minor Serous and Clear Cell Components Adversely Affect Prognosis in ‘‘Mixed-Type’’ Endometrial Carcinomas: A Clinicopathologic Study of 36 Stage-I Cases
- p53 and ovarian carcinoma survival: an Ovarian Tumor Tissue Analysis consortium study
- Clear cell carcinoma of the endometrium is characterized by a distinctive profile of p53, Ki-67, estrogen, and progesterone receptor expression.
- Diagnostic Accuracy of Alpha-Methylacyl-CoA Racemase Immunohistochemical Expression for the Diagnosis of Ovarian and Endometrial Clear Cell Carcinomas